Clinical Chemistry Test Questions – Flashcards
Unlock all answers in this set
Unlock answerslow free PSA fraction or elevated bound PSA fraction PSAfree:PSAtotal <10% correlates with? |
Prostate cancer PSA=protease-->minimize the viscosity of the ejaculate |
Prostatic manipulation and instrumentation --> effect - PSAtotal - PSAfree |
- minimal - markedly=> measure before/several weeks after manipulation |
Specimen handling PSAfree |
processed within 2hrs / freeze -->less stable than bound PSA |
When % PSAfree measurement-->advantage? |
prostate volume < 60cc |
PSAtotal = 2.5 - 4.0 ?test can improve prostate Ca diagnosis |
increased pro-PSA and truncated PSA isoforms1 1pPSA-->anomalous clipping |
Correlation between PSA and tm reccurence |
weak in first 5yrs post treatment preop--> PSA ~ tumor volume and stage
|
Nonneoplastic coditions a/w elevated CEA1 |
Smoking, peptic ulcer dz,IBD,pancreatitis, hypothyroidism, biliary/bowel obstruction, cirrhosis 1CEA < 10ng/mL |
CEA elevations in malignancies other than colon |
Gastric(well diff, intest. type), breast, lung,pancreas,cervical,urothelial, MTC |
Colorectal Ca and degree of CEA elevation Affected by? |
Tumor stage, grade, site (L>R), ploidy obstruction,liver function (metabolism) |
post-treatment surveillance of colorectal Ca |
serial CEA measurements most sensitive--> liver mets poorly sensitive--> locoregional recurrence |
Thyroglobulinserum - Cause of 1. Underestimation 2. Overestimation |
Anti-thyroglobulin Ab's-;10% (nml Indiv.),;20%Pt w thyroid Ca 2. Macro-thyroglobulin ; |
Pt w PTC/FTC and;anti-thyroglobulin Ab's Tumor marker? |
Serial quantitative [anti-thyroglobulin Ab]serum increase<--Ag stimulation<-- recurrence |
Marker for mucinous ovarian Ca, Urothelial Ca & RCC |
Tumor-Associated Trypsin Inhibitor (TATI) also in pancreatic adenoca-->limited specificity (pancreatitis) gastric ca (60%) --> diffuse, infiltrative,signet ring |
TATI expression and tumor prognosis |
Adverse prognostic factor |
Nonneoplastic cause of TATI elevation |
Renal failure Pancreatitis--> degree of elevation ~ severity |
CA 125 Major role in monitoring of which Pt |
Non-mucinous epithelial ovarian neoplasm elevated only ~ 50% --> stage I dz |
elevated CA 125 Nonneoplastic causes |
Pregnancy,fibroids, benign ovarian cysts, pelvic inflammation, ascites, endometriosis |
elevated CA 125 In which nonovarian neoplasms? |
Fallopian tube, endometrium, pancreas,breast, colon |
post-menopausal woman w palpable adnexal mass & CA 125> 65 U/mL Dx? |
Ovarian malignancy ( epithelial, non-mucinous) PPV >95% |
Serum markers for breast Ca |
CA27.29 (more sensitive &specific), CA15-3 --> different epitopes of a single Ag = protein product of breast ca assoc MUC1 gene |
elevated CA27.29/15-3 nonneoplastic causes? |
benign ovarian cysts, liver dz, benign breast dz CA 15-3--> sarcoidosis and lupus |
elevated CA27.29 non-breast malignancies |
Colon, stomach, pancreas, prostate, lung |
Best prognostic markers in breast cancer |
IHC: ER, PR, Her-21 (c-erb-2) Nc staining % of tm cells --> correlates well with biochemical assays (ligand binding) 1IHC & / FISH -->Rx: trastuzumab |
Her-2 assesment in breast cancer |
IHC:Only membranous staining-->only Inv. component 0-3+ --> 2+ => FISH |
Best marker for pancreticobiliary adenoca and assesment to treatment response |
CA19-9 >10001 U/L 1not seen in benign dz ( <100 U/L) |
CA 19-9 What type of Ag |
= Lewis blood group Ag not produced by Le- people |
AFP - physiologic effect Site of synthesis? |
Major component of fetal serum --> ~ albumin Yolk sac, fetal liver/GI tract undetectable-->post partum, adults < 5.4ng/mL benign conditions < 100 ng/mL |
AFP and malignancy |
Yolk sac tm--> [AFP] ~ prognosis HCC -->[AFP] ~ overlap w benign dz Hepatoid variant of gastric Ca |
low level elevation of hCG in non-pregnant woman |
Marijuana use |
Marker for monitoring transplant rejection |
beta2-Micoglobulin --> surface-most nucleated cells -->non-covalent link to MHC I Increased cell turnover1 => elevated beta2M2 1solid tm & hematolymphoid neoplasms,2renal isufficiency |
Raised Alkaline Phosphatase Causes |
-->osteoblastic activity (osteogenic sarcoma, bone mets, active Paget disease of bone) ~ Liver function--> hepatic mets (carcioids~prognosis) |
Pt with gonadal/urologic cancer and elevated placental-type alkaline phosphatase |
Regan isoenzyme of Alk Phos |
modest quantity of 5-HT(serotonin), histamine, catecholamines &5-HTP Dx: Tumor? Location? |
Carcinoid Foregut: stomach, proximal duodenum and lung
|
Only serotonin production in high quantities Dx: Tumor? Location? |
Carcinoid Midgut: distal duodenum,jejunum,ileum,appendix,right colon |
Carcinoid tumor non secretory for indoles Location? |
Distal 1/3 of transverse, descending colon,sigmoid colon and rectum ~hCG |
Most accurate marker for detection of carcinoid tm |
Platelet serotonin --> take up serotonin from the serum @ constant rate --> not affected by diet (tryptophan rich) |
Urine test elevated 5-HIAA DDx: |
Carcinoid --> 20-30% ~ normal (foregut,hindgut) False elevation--> tryptophan rich diet 5-HT--> platelets -->some 5-HT--> renal tubules => 5-HIAA |
Plasma marker in neuroendocrine tm --> Tm burden and treatment response |
Chromogranin A Small cell NE, pheo,carcinoid,islet cell tm
|
Increased [Calcitonin]plasma DDx? |
MTC Hashimoto, C-cell hyperplasia, breast ca 20 -->chronic renal failure, Zollinger-Ellison syndrome |
[Calcitonin]plasma < 10ng/L more sensitive test? |
provocative testing - pentagastrin/omeprazole/Ca++ --> in MEN II families |
MTC Marker of worse prognosis |
high CEA => greater de-differentiation |
Tumor with secretion of: Epinephrine & norepinephrine Dx? |
Pheochromocytoma--> adrenal medulla --> norepinephrine --PNMT-->epinephrine Extra-adrenal tm --> mainly norepinephrine |
Urinary VMA DDx? |
Paraganglioma1/Pheochromocytoma2/ Neuroblastoma3 --> fractionation of catecholamines/metanephrines 1norepinephrine--> normetanephrine --> VMA 2epinephrine--> metanephrine --> VMA 3also homovanillic acid--> metabolic product of DOPA & dopamine |
Most accurate test for initial screening of tumors of chromaffin cells |
1.free Metanephrineplasma 2. Metanephrine/Catecholamineurine plasma catecholamines --> poor sensitivity --> episodic release plasma metanephrines--> long term catecholamine secretion |
free Metanephrineplasma Metanephrine/Catecholamineurine --> equivocal results --> ?test to clarify tests? |
Clonidine suppression test |
low VMA:HVA and prognosis |
<-- poorly difeerentiated Neuroblastoma => worse prognosis |
Monitoring of patients w known hx/o urothelial Ca Marker? DDx of + results |
urinary NMP22--> sensitive,nonspecific (1-6wks post Sx) Inflammation-->rapid cell turnover --> false + Leukocytes--> false + |
Bladder tumor antigen false + |
Stone disease, inflammation, BPH |
Urine test for Prostatic adenoCa |
PCA3/DD3 RNA fro urine sediment--> quantitative real time PCR => # DD3 RNA transcripts (nontranslated mRNA) |
elevated [PSA]serum 1 in prostatic adenoca Cause? |
1Increase leakage into the extracellular matrix KLK3 gene (encodes PSA) --> not upregulated in Prostate adenoca |